Jurickson Profar Facing 162-Game MLB Ban
Jurickson Profar PED suspension 2026
Atlanta Braves outfielder and designated hitter Jurickson Profar is reportedly facing a 162-game suspension after testing positive for performance-enhancing drugs for the second time in his career. According to ESPN, the 33-year-old veteran was hit with the massive penalty on Tuesday, marking a devastating blow for both the player and the Braves organization as they prepare for the 2026 season. Under Major League Baseball’s joint drug agreement, a second violation for performance-enhancing substances triggers an automatic full-season ban without pay. Consequently, Profar is set to forfeit his entire $15 million salary for the 2026 campaign and will be ineligible for any postseason play. This news arrives at a critical juncture for Profar, who was also expected to represent the Netherlands in the upcoming World Baseball Classic later this month.
This reported suspension marks the second time in less than a year that Profar has been flagged for a PED violation. He previously served an 80-game ban at the start of the 2025 season after testing positive for human chorionic gonadotropin (hCG), a hormone typically used to stimulate testosterone production. Despite his initial claims that the first violation was unintentional, this second positive test places him among a select group of only six other players to receive a full-season ban since the league increased penalties for two-time offenders in 2014. According to The Athletic, the MLB Players Association is expected to challenge the ruling, though the success of such appeals for repeat offenders remains historically low. The Braves had originally signed Profar to a three-year, $42 million deal in January 2025 following his breakout All-Star season with the San Diego Padres.
The loss of Profar creates a significant void in the Braves’ lineup, especially as the team was planning to transition him into a primary designated hitter role following his offseason sports hernia surgery. During his abbreviated 2025 campaign, Profar slashed .245/.353/.434 with 14 home runs and 43 RBIs in 80 games, providing a steady veteran presence in the middle of the order. His absence is compounded by a series of other setbacks for Atlanta, including long-term injuries to starting pitchers Spencer Schwellenbach and Hurston Waldrep, as well as a finger injury to shortstop Ha-seong Kim. As reported by AP News, the Braves are now expected to rely more heavily on recent acquisition Mike Yastrzemski in the outfield and may look to 2025 NL Rookie of the Year Drake Baldwin or minor-league signee Dominic Smith to fill the designated hitter vacancy.
Beyond the immediate tactical impact, the suspension significantly clouds the legacy of a player once ranked as the consensus number-one prospect in all of baseball. Profar’s career has been a journey of extreme highs and lows, from his highly anticipated 2012 debut with the Texas Rangers to years of debilitating shoulder injuries that nearly ended his career before he found a resurgence in San Diego. The repeat nature of these violations is likely to spark further debate regarding the effectiveness of the league’s current testing protocols and the pressures faced by veteran players returning from significant surgeries. For those seeking official transaction updates, the Braves have yet to release a formal statement, but the move to place Profar on the restricted list is expected within the next 24 hours. The team will now look to the free-agent market or their internal depth to stabilize a roster that has been battered by both injuries and off-field controversy in the opening weeks of 2026.
